The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
AM23-SN-08-O: Intrauterine Transfusions: Transfusing the Tiniest, Is It The Trickiest? (Enduring)
Credits
1 General Continuing Education (GEN) | 1 Florida Lab Personnel (FLP) | 1 California Nurse (CN) | 1 California Lab Personnel (CLP) | 1 Physician (PHY)
$3000
Standard Price
Members save $5
Intrauterine transfusion (IUT) is a mainstay of antenatal treatment for severe fetal anemia, most often secondary to maternal alloimmunization, with demonstrated improvement in outcomes. IUT is an invasive, technically challenging procedure with specific blood component requirements that is usually performed at specialized centers. Significant variability exists with regard to IUT performance and blood component selection and modifications among centers within the United States and internationally. Successful IUT requires a coordinated, multidisciplinary effort with particular emphasis on communication. There is a lack of standardization and current practices for provision of red blood cells (RBC) and their subsequent modifications reflecting expert opinion and historical single-center experiences. This session aims to present a comprehensive, multi-center overview of IUT, focusing on practical considerations from a combined Maternal-Fetal Medicine and Transfusion Medicine perspective for an audience of transfusion medicine physicians, trainees, and clinical laboratory scientists. The session will cover the clinical indications for IUT and calculations about the blood volume required to correct fetal anemia by IUTs. The steps involved in RBC Product Selection and component processing and modifications for Intrauterine Transfusion and the specific role of Transfusion Medicine and Blood Banking Service will be discussed. Finally, the under-recognized complications, documentation and regulatory issues as it relates to IUT will be discussed.The idiosyncrasies of transfusion documentation and record keeping will be discussed: Per AABB standards, all transfusions must be documented under the patient’s medical record number and any transfusion-related adverse events. Ethical considerations for documentation of intrauterine transfusion for a fetus that is not yet born will be discussed.
Learning Objectives
Identify the clinical indications for intrauterine transfusions (IUTs) and calculate the volume of blood required for the correction of fetal anemia by IUTs.
Discuss the steps involved in RBC Product Selection and component processing and modifications for IUTs and the specific role of Transfusion Medicine and Blood Banking Service
Deliberate on the under-recognized complications, documentation and regulatory Issues as it relates to IUTs.
Director, Cancer and Blood Disorders Institute and Blood Bank/Transfusion Medicine and Apheresis, Johns Hopkins All Children's Hospital, Department of Pathology, Division Transfusion Medicine, Johns Hopkins All Children’s Hospital, St. Petersburg, Florida.
All relevant financial relationships have been mitigated.
By completing the evaluation, you are attesting to watching the presentation in its entirety. A certificate will be immediately provided after submission.
Credits Available
Purchasing this session will automatically provide ownership of all the individually purchasable attached CE products, regardless of their stated individual purchase restrictions.
AM23-SN-08-O: Intrauterine Transfusions: Transfusing the Tiniest, Is It The Trickiest? (Enduring) Evaluation
Join us for an essential panel discussion on cybersecurity in healthcare, where real-world insights and expert analysis come together to enhance your organization's defenses. This session features three distinguished speakers from hospitals and blood centers that have faced cybersecurity attacks…
The future of the blood and biotherapies fields depends on our ability to prepare a new generation of leaders and skilled professionals to continue advancing the field…
Many blood operators around the world are implementing individualized donor assessments that welcome more trans, non-binary, and gender-diverse people to donate…